FDA Withdraws Notice on Fee Rates for Over-the-Counter Monograph Drug User Fee Program

Summary

The US Department of Health and Human Services is withdrawing a December 2020 FDA notice due to a lack of delegated authority, and has ordered the agency to stop collecting fees for the Over-the-Counter Drug Monograph User Fee Program until further action is announced.